Spyre Therapeutics Shares Rise Last Year as $10.5 Million Purchase Raises Stake to $78 Million
Commodore Capital announced the purchase of 400,161 shares of Spyre Therapeutics (NASDAQ:SYRE)an estimated trade of $10.46 million based on quarterly average price, according to an SEC filing dated February 17, 2026. According to an SEC filing dated February 17, 2026, Commodore Capital increased its position in Spyre Therapeutics by 400,161 shares during the fourth quarter….